NDC Pricing 0781-7296-85 Albuterol Sulfate
Aerosol, Metered Respiratory (inhalation)

Current Pricing Information

The most recent wholesale price for a package of 1 CANISTER in 1 CARTON > 200 AEROSOL, METERED in 1 CANISTER is $3.46388 per billable unit.Albuterol Sulfate is a a human prescription drug labeled by Sandoz Inc and is priced per "GM" unit. The pricing information is based on the National Average Drug Acquisition Cost (NADAC) and is effective since 09-21-2022.

NADAC pricing data is based on random monthly surveys and reflects the average drug invoice price paid by retail community pharmacies to wholesalers. The data source for this pricing survey was a C/I - Chain or Independent Pharmacy.

Field Name Field Value
Price per Unit $3.46388
Effective Date Effective Date
The effective date of the NADAC Per Unit cost.
09-21-2022
Pricing Unit Pricing Unit
Indicates the pricing unit for the associated NDC (ML, GM or EA).
GM
NDC Code 0781-7296-85
Package Description 1 CANISTER in 1 CARTON > 200 AEROSOL, METERED in 1 CANISTER
Pharmacy Type Indicator Pharmacy Type Indicator
The source of pharmacy survey data used to calculate the NADAC. 'C/I' indicates data was collected from surveys of Chain/Independent pharmacies. Other pharmacy type indicators are not used at this time.
C/I - Chain or Independent Pharmacy
Explanation Code Explanation Code
The source of pharmacy survey data used to calculate the NADAC. 'C/I' indicates data was collected from surveys of Chain/Independent pharmacies. Other pharmacy type indicators are not used at this time.
Code 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
Classification for Rate Setting Classification for Rate Setting
Indicates whether the NDC was considered brand (B) or generic (G) for the NADAC rate calculation process. If the NDC was considered brand (B) and approved under an Abbreviated New Drug Application (ANDA), the indicator is shown as (B-ANDA).
G - Generic
As of Date 09-28-2022

The Centers for Medicare and Medicaid Services (CMS) compile the NADAC data based on random monthly surveys on more than 60,000 pharmacies from all 50 states and the District of Columbia. NADAC pricing information is NOT the price paid by end-customers but instead the price paid by pharmacies to drug wholesalers and distributors.

View Package Details

Pricing History

The NADAC wholesale price of Albuterol Sulfate 0781-7296-85 has fluctuated from a low of $3.46388 to a high of $4.39818 per billable unit over a period of 1 year and 4 months. The historical price table below includes all the price changes based on the monthly surveys of retail and chain pharmacies taken by the Centers for Medicare and Medicaid Services (CMS).

Effective Date Price per Unit Pricing Unit Pharmacy Type Indicator Explanation Code Classification Rate Setting
09-21-2022$3.46388GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
08-17-2022$3.55916GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
07-20-2022$3.65036GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
06-22-2022$3.77614GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
05-18-2022$3.78802GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
04-20-2022$3.94565GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
03-23-2022$3.77137GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
02-23-2022$3.85314GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
01-19-2022$4.37638GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
12-22-2021$4.10228GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
11-17-2021$4.09135GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
10-20-2021$4.02203GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
09-22-2021$4.08429GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
08-18-2021$4.22791GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
07-21-2021$4.30340GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
06-23-2021$3.99130GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
05-19-2021$4.32090GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic
05-12-2021$4.39818GMC/I - Chain or Independent PharmacyCode 1: The NADAC was calculated using information from the most recently completed pharmacy survey.
Code 5: The NADAC was calculated based on package size.
Code 6: The CMS Covered Outpatient File drug category type of S/I/N (Single Source/Innovator/Non-Innovator) has not been applied. Most S/I drugs with the same strength, dosage form and route of administration were grouped together for the purpose of the NADAC calculation and N drugs were also grouped together. In some cases, however, in calculating a NADAC, the CMS S/I/N designation was not applied when the state Medicaid brand or generic payment practices for these drugs generally differed from the CMS Covered Outpatient File designation.
G - Generic

The pricing data in this page is based on the National Average Drug Acquisition Cost (NADAC). The NADAC data is compiled by CMS and updated every week. The NADAC dataset is designed to help create a national benchmark reflective of the wholesale prices paid by retails pharmacies to acquire prescription and over-the-counter drugs. The pricing information in this page reflects the reference point that healthcare programs like Medicaid may use to reimburse pharmacies. The pricing data is this page is NOT the price paid by end-customers.

NADAC Pricing Data Last Updated on: September 28, 2022